JW (Cayman) Therapeutics Co. Ltd. (HK:2126) has released an update.
JW (Cayman) Therapeutics Co. Ltd has scheduled an upcoming board meeting on August 28, 2024, to review and approve its unaudited interim results for the first half of the year and to discuss additional business matters. This meeting is key for investors as the results will provide insight into the company’s recent performance. The announcement was made by the company’s Chairman, Yiping James Li, confirming the engagement of the board’s diverse team of directors.
For further insights into HK:2126 stock, check out TipRanks’ Stock Analysis page.
